OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EphA2 phosphorylation at Ser897 by the Cdk1/MEK/ ERK/RSK pathway regulates M‐phase progressionviamaintenance of cortical rigidity
Yuichiro Kaibori, Youhei Saito, Yuji Nakayama
The FASEB Journal (2019) Vol. 33, Iss. 4, pp. 5334-5349
Open Access | Times Cited: 25

Showing 25 citing articles:

Targeting CDK1 in cancer: mechanisms and implications
Qiushi Wang, Ann M. Bode, Tianshun Zhang
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 84

Eph receptors and ephrins in cancer progression
Elena B. Pasquale
Nature reviews. Cancer (2023) Vol. 24, Iss. 1, pp. 5-27
Open Access | Times Cited: 55

Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK/MDM2/p53 axis
Hao Yan, Wentong Wu, Yuhuai Hu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24

OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway
Mingxin Ci, Gaichao Zhao, Chongyang Li, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 9

Dihydroartemisinin inhibits EphA2/PI3K/Akt pathway-mediated malignant behaviors and vasculogenic mimicry in glioma stem cells
Huangde Fu, Shengtian Wu, Hechun Shen, et al.
Heliyon (2025) Vol. 11, Iss. 3, pp. e42095-e42095
Open Access | Times Cited: 1

Cellular stress induces non-canonical activation of the receptor tyrosine kinase EphA2 through the p38-MK2-RSK signaling pathway
Yue Zhou, Ryota Oki, Akihiro Tanaka, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 5, pp. 104699-104699
Open Access | Times Cited: 10

Effect of EphA2 knockdown on melanoma metastasis depends on intrinsic ephrinA1 level
Jing Mo, Xiulan Zhao, Xueyi Dong, et al.
Cellular Oncology (2020) Vol. 43, Iss. 4, pp. 655-667
Closed Access | Times Cited: 22

Upregulation of ATP Binding Cassette Subfamily C Member 5 facilitates Prostate Cancer progression and Enzalutamide resistance via the CDK1-mediated AR Ser81 Phosphorylation Pathway
Guangjie Ji, Shiming He, Cong Huang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 7, pp. 1613-1628
Open Access | Times Cited: 17

Duck hepatitis A virus type 1 mediates cell cycle arrest in the S phase
Yuanzhi Liu, Yanglin Li, Mingshu Wang, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 9

NCAPG-mediated CDK1 promotes malignant progression of non-small cell lung cancer via ERK signaling activation
Yilin Wu, Ming Yang, Ming Chen, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 11, pp. 5338-5350
Closed Access | Times Cited: 1

Protein kinase C phosphorylates the EphA2 receptor on serine 892 in the regulatory linker connecting the kinase and SAM domains
Marina P. Gehring, Elena B. Pasquale
Cellular Signalling (2020) Vol. 73, pp. 109668-109668
Open Access | Times Cited: 10

Ciliogenesis and autophagy are coordinately regulated by EphA2 in the cornea to maintain proper epithelial architecture
Nihal Kaplan, Sijia Wang, Junyi Wang, et al.
The Ocular Surface (2021) Vol. 21, pp. 193-205
Open Access | Times Cited: 8

Signaling Pathways That Regulate Normal and Aberrant Red Blood Cell Development
Mark C. Wilkes, Aya Shibuya, Kathleen M. Sakamoto
Genes (2021) Vol. 12, Iss. 10, pp. 1646-1646
Open Access | Times Cited: 8

Eph signal inhibition potentiates the growth-inhibitory effects of PLK1 inhibition toward cancer cells
Ryuzaburo Yuki, Hiroki Kuwajima, Ryoko Ota, et al.
European Journal of Pharmacology (2023) Vol. 963, pp. 176229-176229
Closed Access | Times Cited: 2

Kinase activity-independent role of EphA2 in the regulation of M-phase progression
Yuichiro Kaibori, Kiriko Katayama, Yuka Tanaka, et al.
Experimental Cell Research (2020) Vol. 395, Iss. 2, pp. 112207-112207
Closed Access | Times Cited: 5

Combination Treatment of OSI-906 with Aurora B Inhibitor Reduces Cell Viability via Cyclin B1 Degradation-Induced Mitotic Slippage
Yuki Ikeda, Ryuji Yasutake, Ryuzaburo Yuki, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5706-5706
Open Access | Times Cited: 5

CCR3 blockage elicits polyploidization associated with the signatures of epithelial-mesenchymal transition in carcinoma cell lines
Yuichiro Kaibori, Daisuke Nagakubo
Cancer Gene Therapy (2022) Vol. 30, Iss. 1, pp. 137-148
Closed Access | Times Cited: 3

Simvastatin activates the spindle assembly checkpoint and causes abnormal cell division by modifying small GTPases
Junna Tanaka, Hiroki Kuwajima, Ryuzaburo Yuki, et al.
Cellular Signalling (2024) Vol. 119, pp. 111172-111172
Closed Access

TNK2 Inhibitor (R)−9bMS Causes Polyploidization Through Mitotic Failure by Targeting Aurora B
M Murata, Hiroki Kuwajima, Junna Tanaka, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 8
Closed Access

Phosphorylation of Ephexin4 at Ser-41 contributes to chromosome alignment via RhoG activation in cell division
Ryuji Yasutake, Hiroki Kuwajima, Ryuzaburo Yuki, et al.
Journal of Biological Chemistry (2024), pp. 108084-108084
Open Access

Allosteric Regulation of the EphA2 Receptor Intracellular Region by Serine/Threonine Kinases
Bernhard C. Lechtenberg, Marina P. Gehring, Taylor P. Light, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1

Phosphotyrosine proteomics in cells synchronized at monopolar cytokinesis reveals EphA2 as functioning in cytokinesis
Nanami Hasegawa, M Hongo, Misaki Okada, et al.
Experimental Cell Research (2023) Vol. 432, Iss. 1, pp. 113783-113783
Closed Access

Regorafenib inhibits EphA2 phosphorylation damages the liver via ERK/MDM2/p53 axis
Hao Yan, Wentong Wu, Yuhuai Hu, et al.
Research Square (Research Square) (2022)
Open Access

Page 1

Scroll to top